A. Green

发表

Changes in English medication safety indicators throughout the COVID-19 pandemic: a federated analysis of 57 million patients' primary care records in situ using OpenSAFELY

A. Walker, S. Bacon, C. Bates, 2022, medRxiv.

Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study

Amir, J. Sterne, E. Williamson, 2022, medRxiv.

Effectiveness of BNT162b2 booster doses in England: an observational study in OpenSAFELY-TPP

M. Hernán, E. Williamson, A. Walker, 2022, medRxiv.

Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform

R. Eggo, A. Walker, S. Bacon, 2022, BMJ.

Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe COVID-19 outcomes in non-hospitalised patients: an observational cohort study using the OpenSAFELY platform

A. Walker, S. Bacon, C. Bates, 2022, medRxiv.

Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised patients on kidney replacement therapy: observational cohort study using the OpenSAFELY-UKRR linked platform and SRR database

M. Scanlon, H. Curtis, A. Mehrkar, 2022, medRxiv.

Waning effectiveness of BNT162b2 and ChAdOx1 COVID-19 vaccines over six months since second dose: a cohort study using linked electronic health records

M. Hernán, J. Sterne, R. Keogh, 2022, medRxiv.

Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY

A. Walker, S. Bacon, C. Bates, 2023, BMJ medicine.

Potentially inappropriate prescribing of DOACs to people with mechanical heart valves: A federated analysis of 57.9 million patients' primary care records in situ using OpenSAFELY.

K. Bhaskaran, L. Smeeth, R. Eggo, 2022, Thrombosis research.

The impact of the COVID-19 pandemic on Antipsychotic Prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: A federated analysis of 59 million patients primary care records in situ using OpenSAFELY

A. Walker, S. Bacon, C. Bates, 2023, medRxiv.

Mortality among Care Home Residents in England during the first and second waves of the COVID-19 pandemic: an observational study of 4.3 million adults over the age of 65

K. Bhaskaran, L. Smeeth, R. Eggo, 2022, The Lancet Regional Health - Europe.

Challenges in Estimating the Effectiveness of COVID-19 Vaccination Using Observational Data

K. Bhaskaran, L. Smeeth, M. Hernán, 2023, Annals of Internal Medicine.

Trends, regional variation and clinical characteristics of recipients of antivirals and neutralising monoclonal antibodies for non-hospitalised COVID-19: a descriptive cohort study of 23.4 million people in OpenSAFELY

A. Walker, S. Bacon, C. Bates, 2022, medRxiv.

Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based, observational cohort study using the OpenSAFELY platform

Marwa Al Arab, K. Bhaskaran, L. Smeeth, 2023, EClinicalMedicine.

Eleven key measures for monitoring general practice clinical activity during COVID-19 using federated analytics on 48 million adults' primary care records through OpenSAFELY

A. Walker, S. Bacon, C. Bates, 2022, medRxiv.

Impact of COVID-19 on recorded blood pressure screening and hypertension management in England: An analysis of monthly changes in Quality and Outcomes Framework indicators in OpenSAFELY

A. Walker, S. Bacon, C. Bates, 2023, medRxiv.

Eleven key measures for monitoring general practice clinical activity during COVID-19: A retrospective cohort study using 48 million adults’ primary care records in England through OpenSAFELY

A. Walker, S. Bacon, C. Bates, 2023, eLife.

Changes in medication safety indicators in England throughout the covid-19 pandemic using OpenSAFELY: population based, retrospective cohort study of 57 million patients using federated analytics

A. Walker, S. Bacon, C. Bates, 2023, BMJ medicine.

Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study

J. Sterne, E. Williamson, A. Walker, 2023, BMJ Open.

Effectiveness of Sotrovimab and Molnupiravir in community settings in England across the Omicron BA.1 and BA.2 sublineages: emulated target trials using the OpenSAFELY platform

A. Walker, C. Bates, H. Curtis, 2023, medRxiv.

Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records

M. Hernán, J. Sterne, R. Keogh, 2022, BMJ.

Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT).

K. Bhaskaran, R. Eggo, A. Mehrkar, 2024, The Lancet regional health. Europe.

Clinical coding of long COVID in primary care 2020–2023 in a cohort of 19 million adults: an OpenSAFELY analysis

K. Bhaskaran, R. Eggo, A. Mehrkar, 2024, EClinicalMedicine.

Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: a federated analysis of 59 million patients’ primary care records in situ using OpenSAFELY

S. Bacon, C. Bates, C. Morton, 2023, BMJ Mental Health.